Search research articles
Contact Us
Filters
Showing results (171-180 of 206) with videos related to
Page
of 21
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2023
Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Nan Deng, Laura Reyes-Uribe, Johannes F Fahrmann, et al.
Cancer
|
December 1, 2018
The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia
Patrick Williams, Sreyashi Basu, Guillermo Garcia-Manero, et al.
Cancer Discovery
|
November 10, 2018
Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study
Naval Daver, Guillermo Garcia-Manero, Sreyashi Basu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 28, 2016
A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune Profiling
Heather L McArthur, Adi Diab, David B Page, et al.
Nature
|
November 17, 2022
T cells specific for α-myosin drive immunotherapy-related myocarditis
Margaret L Axelrod, Wouter C Meijers, Elles M Screever, et al.
Nature Medicine
|
November 14, 2018
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Yinghong Wang, Diana H Wiesnoski, Beth A Helmink, et al.
Cell Research
|
January 14, 2015
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25
Dalil Hannani, Marie Vétizou, David Enot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2024
A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer
Ana M Aparicio, Rebecca S S Tidwell, Shalini S Yadav, et al.
Nature
|
July 24, 2024
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy
Hussein Sultan, Yoshiko Takeuchi, Jeffrey P Ward, et al.
Nature Medicine
|
November 28, 2018
Author Correction: Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Yinghong Wang, Diana H Wiesnoski, Beth A Helmink, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 206) with videos related to
Sort By:
Page
of 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2023
Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Nan Deng, Laura Reyes-Uribe, Johannes F Fahrmann, et al.
Cancer
|
December 1, 2018
The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia
Patrick Williams, Sreyashi Basu, Guillermo Garcia-Manero, et al.
Cancer Discovery
|
November 10, 2018
Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study
Naval Daver, Guillermo Garcia-Manero, Sreyashi Basu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 28, 2016
A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune Profiling
Heather L McArthur, Adi Diab, David B Page, et al.
Nature
|
November 17, 2022
T cells specific for α-myosin drive immunotherapy-related myocarditis
Margaret L Axelrod, Wouter C Meijers, Elles M Screever, et al.
Nature Medicine
|
November 14, 2018
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Yinghong Wang, Diana H Wiesnoski, Beth A Helmink, et al.
Cell Research
|
January 14, 2015
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25
Dalil Hannani, Marie Vétizou, David Enot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2024
A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer
Ana M Aparicio, Rebecca S S Tidwell, Shalini S Yadav, et al.
Nature
|
July 24, 2024
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy
Hussein Sultan, Yoshiko Takeuchi, Jeffrey P Ward, et al.
Nature Medicine
|
November 28, 2018
Author Correction: Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Yinghong Wang, Diana H Wiesnoski, Beth A Helmink, et al.
Page
of 21